Gedeon Richter Plc.

Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest, Hungary, founded in 1901 by pharmacist Gedeon Richter. As the largest pharmaceutical firm in Central and Eastern Europe, it employs approximately 13,000 people worldwide and maintains operations in over 100 countries, including subsidiaries in the UK, Poland, Romania, India, Germany, Mexico, Brazil, and Colombia. The company specializes in developing and manufacturing innovative products across key therapeutic areas such as women's health, neuroscience, oncology, cardiovascular diseases, and biotechnology, including biosimilars and generics. Women's healthcare stands out as a core priority, with a comprehensive gynecological portfolio addressing needs from contraception to infertility treatments. Gedeon Richter invests significantly in research and development, boasting the region's largest R&D unit and allocating around 110 million euros annually to advance its pipeline. It operates manufacturing facilities in Budapest, Dorog, and Debrecen, emphasizing innovation to combat illness and improve global health outcomes. Primarily listed on the Budapest Stock Exchange, Gedeon Richter plays a pivotal role in the pharmaceutical sector, blending historical expertise with modern biotechnological advancements.